130 related articles for article (PubMed ID: 3652058)
1. Continuous venous infusion of doxorubicin in advanced sarcomas.
Samuels BL; Vogelzang NJ; Ruane M; Simon MA
Cancer Treat Rep; 1987 Oct; 71(10):971-2. PubMed ID: 3652058
[TBL] [Abstract][Full Text] [Related]
2. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
4. Concomitant radiation-doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomas: preliminary results.
Toma S; Palumbo R; Sogno G; Canavese G; Barra S; Marziano C; Serrano J; Albanese E; Rosso R
Anticancer Res; 1991; 11(6):2085-9. PubMed ID: 1776844
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
Pisters PW; Patel SR; Prieto VG; Thall PF; Lewis VO; Feig BW; Hunt KK; Yasko AW; Lin PP; Jacobson MG; Burgess MA; Pollock RE; Zagars GK; Benjamin RS; Ballo MT
J Clin Oncol; 2004 Aug; 22(16):3375-80. PubMed ID: 15310783
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Schütte J; Kellner R; Seeber S
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
[TBL] [Abstract][Full Text] [Related]
7. Concomitant chemo-radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
Toma S; Canavese G; Grimaldi A; Ravera G; Ugolini D; Percivale P; Badellino F
Oncol Rep; 2003; 10(3):641-7. PubMed ID: 12684637
[TBL] [Abstract][Full Text] [Related]
8. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
9. Combined chemo-radiation and hyperthermia for locally advanced soft tissue sarcoma: response and toxicity.
Uno T; Itami J; Kato H
Anticancer Res; 1995; 15(6B):2655-7. PubMed ID: 8669842
[TBL] [Abstract][Full Text] [Related]
10. Comparison of doxorubicin with cycloleucine in the treatment of sarcomas.
Savlov ED; MacIntyre JM; Knight E; Wolter J
Cancer Treat Rep; 1981; 65(1-2):21-7. PubMed ID: 7013976
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma.
Schütte J; Mouridsen HT; Steward W; Santoro A; van Oosterom AT; Somers R; Blackledge G; Verweij J; Dombernowsky P; Thomas D
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S204-9. PubMed ID: 8453699
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
Huang YH; Wen XP; Hu L
Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
[TBL] [Abstract][Full Text] [Related]
16. [Intraarterial high-dose adriamycin for patients with skeletal or soft tissue sarcoma].
Yoh S; Takagishi N; Iwasaki H; Eimoto T; Ono Y; Okasaki M
Gan No Rinsho; 1983 Aug; 29(10):1263-73. PubMed ID: 6632206
[TBL] [Abstract][Full Text] [Related]
17. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
18. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
Tursz T
Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500
[TBL] [Abstract][Full Text] [Related]
19. High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia.
Wheeler RH; Ensminger WD; Thrall JH; Anderson JL
Cancer Treat Rep; 1982 Mar; 66(3):493-8. PubMed ID: 7060037
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]